Recent Finacing
Recent Raise
Isofol Medical is a clinical-stage pharma developing Modufolin, folate biomodulator bypassing metabolic activation to improve chemotherapy, with trials in colorectal cancer and osteosarcoma, partnering with Merck Millipore and Recipharm
Focus Areas
Recent Investors
Total Raised
Funding round
Investor